Back to Search
Start Over
Tiziana gets US patent on use of Milciclib in combo with tyrosine kinase inhibitors to treat HCC and other cancers
- Source :
- PharmaBiz. August 24, 2020
- Publication Year :
- 2020
-
Abstract
- Tiziana Life Sciences plc, a biotechnology company focused on innovative therapeutics for oncology, inflammation and infectious diseases, announces that the United States Patent and Trademark Office (USPTO) has granted a [...]
Details
- Language :
- English
- Database :
- Gale General OneFile
- Journal :
- PharmaBiz
- Publication Type :
- Periodical
- Accession number :
- edsgcl.633377825